Literature DB >> 21658319

Inflammatory cells, cytokines and matrix metalloproteinases in amicrobial pustulosis of the folds and other neutrophilic dermatoses.

A V Marzano1, M Cugno, V Trevisan, R Lazzari, D Fanoni, E Berti, C Crosti.   

Abstract

Amicrobial pustulosis of the folds (APF) is a rare cutaneous disease characterized by relapsing sterile pustules frequently associated with autoimmune disorders. Although APF pathophysiology is still undefined, scattered reports suggest involvement of neutrophils. The aim of the present study is to evaluate the role of the skin inflammatory infiltrate, selected multifunctional cytokines and effectors of tissue damage in APF and other neutrophilic dermatoses. We studied, by immunohistochemical methods, inflammatory cell markers (CD3, CD163, myeloperoxidase), cytokines (TNF-alpha, IL-8, IL-17), metalloproteinases (MMP-2, MMP-9) and vascular-endothelial-growth-factor (VEGF) in lesional skin from six patients with APF, 11 with pyoderma gangrenosum (PG), 7 with Sweet's syndrome, and in 20 normal skin samples. Immunoreactivities of CD3, CD163, myeloperoxidase, TNF-alpha, IL-8, IL-17, MMP-2, MMP-9 and VEGF were significantly higher in APF, PG and Sweet's syndrome than in controls (p=0.0001). IL-8 was more expressed in PG than in APF (P=0.002) and Sweet's syndrome (p=0.001). In APF, MMP-9 reactivity was higher than in Sweet's syndrome (p=0.035), but less intense than in PG (p=0.020). Our study supports the role of proinflammatory cytokines/chemokines and MMPs as important effectors for the tissue damage in APF similarly to classic neutrophilic dermatoses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658319     DOI: 10.1177/039463201102400218

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  13 in total

Review 1.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

2.  Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.

Authors:  Syed M Kazmi; Naveen Pemmaraju; Keyur P Patel; Philip R Cohen; Naval Daver; Kathy M Tran; Farhad Ravandi; Madeleine Duvic; Guillermo Garcia-Manero; Sherry Pierce; Aziz Nazha; Gautam Borthakur; Hagop Kantarjian; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-12-24

Review 3.  A Comprehensive Review of Neutrophilic Diseases.

Authors:  Angelo V Marzano; Alessandro Borghi; Daniel Wallach; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.

Authors:  Heather E Wheeler; Anna González-Neira; Guillermo Pita; Julio-Cesar de la Torre-Montero; Rosario Alonso; Luis A Lopez-Fernandez; Emilio Alba; Miguel Martín; M Eileen Dolan
Journal:  Pharmacogenet Genomics       Date:  2014-05       Impact factor: 2.089

Review 5.  Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.

Authors:  Quindelyn S Cook; Carlton J Zdanski; Craig N Burkhart; Paul B Googe; Patrick Thompson; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2019-05-14       Impact factor: 4.919

Review 6.  Pyoderma gangrenosum: challenges and solutions.

Authors:  Ana Gameiro; Neide Pereira; José Carlos Cardoso; Margarida Gonçalo
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-28

7.  Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.

Authors:  Zahra Ahmadinejad; Sedigeh Mansouri; Vahid Ziaee; Yahya Aghighi; Mohammad-Hassan Moradinejad; Fatemeh Fereshteh-Mehregan
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

8.  Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration.

Authors:  Christine Mayer; Silvia Darb-Esfahani; Anne-Sophie Meyer; Katrin Hübner; Joachim Rom; Christof Sohn; Ioana Braicu; Jalid Sehouli; G Maria Hänsch; Matthias M Gaida
Journal:  J Cancer       Date:  2016-03-10       Impact factor: 4.207

9.  Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease.

Authors:  Hiroi Kusaka; Katsuya Nagatani; Takeo Sato; Seiji Minota
Journal:  BMJ Case Rep       Date:  2020-04-08

Review 10.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.